Backing Down On Forward Funding? HHS Now Says It Won’t Make Multiple Year Awards Until September
In Brief: AACR Lectures Listed; Winn Heads Community Oncology At MDA; Henderson ACS Grant Renewed
FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin
B.J. Kennedy Receives ACCC Award, Says More Medical Oncologists Are Still Needed
Trombold Tells How Scripps Raises Money for Cancer Center, Gets Independent From “Whiny Administrator”
McKenna Sees Budget Cuts as Threat to Year 2000 Goals Urges Stepped Up Efforts Against Tobacco Industry
Trending Stories
- How George Tidmarsh crossed the FDA-industry Rubicon
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval









